顺铂/伊立替康对比顺铂/依托泊苷用于广泛期小细胞肺癌患者的随机III期试验 - Suppr

Suppr

超能文献

Randomized phase III trial of cisplatin/irinotecan versus cisplatin/etoposide in patients with extensive-stage small-cell lung cancer.

作者信息

Lara Primo N, Gandara David R, Natale Ronald B

机构信息

University of California, Davis Cancer Center, Sacramento, CA 95817-2229, USA.

出版信息

Clin Lung Cancer. 2006 Mar;7(5):353-6. doi: 10.3816/CLC.2006.n.019.

DOI:10.3816/CLC.2006.n.019

PMID:16640809

Abstract

摘要

相似文献

Randomized phase III trial of cisplatin/irinotecan versus cisplatin/etoposide in patients with extensive-stage small-cell lung cancer.

Clin Lung Cancer. 2006 Mar;7(5):353-6. doi: 10.3816/CLC.2006.n.019.

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer.

N Engl J Med. 2002 Jan 10;346(2):85-91. doi: 10.1056/NEJMoa003034.

New state of the art in small-cell lung cancer.

Oncology (Williston Park). 2001 Jan;15(1 Suppl 1):8-10.

Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903.

Clin Cancer Res. 2005 Aug 1;11(15):5534-8. doi: 10.1158/1078-0432.CCR-04-1771.

Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer.

J Clin Oncol. 2006 May 1;24(13):2038-43. doi: 10.1200/JCO.2005.04.8595.

Lung cancer--time to move on from chemotherapy.

N Engl J Med. 2002 Jan 10;346(2):126-8. doi: 10.1056/NEJM200201103460211.

Irinotecan-cisplatin therapy for patients with extensive-stage small cell lung cancer: use patterns among American medical oncologists 2000-2006.

J Thorac Oncol. 2007 Oct;2(10):953-6. doi: 10.1097/JTO.0b013e318153f8db.

Complement and correction for meta-analysis of patients with extensive-stage small cell lung cancer managed with irinotecan/cisplatin versus etoposide/cisplatin as first-line chemotherapy.

J Thorac Oncol. 2011 Feb;6(2):406-8; author reply 408. doi: 10.1097/JTO.0b013e3182061d8c.

Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer.

Br J Cancer. 2008 Feb 26;98(4):693-6. doi: 10.1038/sj.bjc.6604233. Epub 2008 Feb 5.

Irinotecan plus cisplatin in small-cell lung cancer.

Oncology (Williston Park). 2002 Sep;16(9 Suppl 9):39-43.

引用本文的文献

Randomized phase 2 study comparing irinotecan versus amrubicin as maintenance therapy after first-line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401).

Thorac Cancer. 2021 Jul;12(14):2113-2121. doi: 10.1111/1759-7714.14048. Epub 2021 Jun 2.

Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer.

Cancer Immunol Immunother. 2019 Mar;68(3):517-527. doi: 10.1007/s00262-018-2287-9. Epub 2018 Dec 27.

Comparing the adverse effects of platinum in combination with etoposide or irinotecan in previously untreated small-cell lung cancer patients with extensive disease: A network meta-analyses.

Thorac Cancer. 2017 May;8(3):170-180. doi: 10.1111/1759-7714.12420. Epub 2017 Mar 6.

[First-line Chemotherapy for Extensive-disease Small Cell Lung Cancer:  A Network Meta-analysis].

Zhongguo Fei Ai Za Zhi. 2016 Apr 20;19(4):184-91. doi: 10.3779/j.issn.1009-3419.2016.04.02.

Platinum versus non-platinum chemotherapy regimens for small cell lung cancer.

Cochrane Database Syst Rev. 2015 Aug 2;2015(8):CD006849. doi: 10.1002/14651858.CD006849.pub3.

High-grade neuroendocrine carcinoma of the colon, long-term survival in advanced disease.

Med Oncol. 2011 Dec;28 Suppl 1:S169-74. doi: 10.1007/s12032-010-9674-1. Epub 2010 Sep 14.

Features of potentially predictive biomarkers of chemotherapeutic efficacy in small cell lung cancer.

J Thorac Oncol. 2010 Apr;5(4):484-90. doi: 10.1097/JTO.0b013e3181ccb27b.

Novel systemic therapies for small cell lung cancer.

J Natl Compr Canc Netw. 2008 Mar;6(3):315-22. doi: 10.6004/jnccn.2008.0026.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验